These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

771 related items for PubMed ID: 3016503

  • 1. Sodium regulation of agonist binding at opioid receptors. I. Effects of sodium replacement on binding at mu- and delta-type receptors in 7315c and NG108-15 cells and cell membranes.
    Puttfarcken P, Werling LL, Brown SR, Cote TE, Cox BM.
    Mol Pharmacol; 1986 Aug; 30(2):81-9. PubMed ID: 3016503
    [Abstract] [Full Text] [Related]

  • 2. Sodium regulation of agonist binding at opioid receptors. II. Effects of sodium replacement on opioid binding in guinea pig cortical membranes.
    Werling LL, Brown SR, Puttfarcken P, Cox BM.
    Mol Pharmacol; 1986 Aug; 30(2):90-5. PubMed ID: 3016504
    [Abstract] [Full Text] [Related]

  • 3. Multiple agonist-affinity states of opioid receptors: regulation of binding by guanyl nucleotides in guinea pig cortical, NG108-15, and 7315c cell membranes.
    Werling LL, Puttfarcken PS, Cox BM.
    Mol Pharmacol; 1988 Apr; 33(4):423-31. PubMed ID: 2833686
    [Abstract] [Full Text] [Related]

  • 4. Effects of chronic morphine exposure on opioid inhibition of adenylyl cyclase in 7315c cell membranes: a useful model for the study of tolerance at mu opioid receptors.
    Puttfarcken PS, Werling LL, Cox BM.
    Mol Pharmacol; 1988 May; 33(5):520-7. PubMed ID: 2835651
    [Abstract] [Full Text] [Related]

  • 5. Reversible and irreversible binding of beta-funaltrexamine to mu, delta and kappa opioid receptors in guinea pig brain membranes.
    Tam SW, Liu-Chen LY.
    J Pharmacol Exp Ther; 1986 Nov; 239(2):351-7. PubMed ID: 3021954
    [Abstract] [Full Text] [Related]

  • 6. Opioid binding to rat and guinea-pig neural membranes in the presence of physiological cations at 37 degrees C.
    Werling LL, Zarr GD, Brown SR, Cox BM.
    J Pharmacol Exp Ther; 1985 Jun; 233(3):722-8. PubMed ID: 2989494
    [Abstract] [Full Text] [Related]

  • 7. Multiple opiate binding sites in the central nervous system of the rabbit. Large predominance of a mu subtype in the cerebellum and characterization of a kappa subtype in the thalamus.
    Meunier JC, Kouakou Y, Puget A, Moisand C.
    Mol Pharmacol; 1983 Jul; 24(1):23-9. PubMed ID: 6306437
    [Abstract] [Full Text] [Related]

  • 8. Comparison of [125I]beta-endorphin binding to rat brain and NG108-15 cells using a monoclonal antibody directed against the opioid receptor.
    Bidlack JM, O'Malley WE, Schulz R.
    Mol Pharmacol; 1988 Feb; 33(2):170-7. PubMed ID: 2828912
    [Abstract] [Full Text] [Related]

  • 9. Effect of chronic D-Ala,2 D-Leu5-enkephalin or pertussis toxin treatment on the high-affinity state of delta opioid receptor in neuroblastoma x glioma NG108-15 hybrid cells.
    Law PY, Hom DS, Loh HH.
    J Pharmacol Exp Ther; 1991 Feb; 256(2):710-6. PubMed ID: 1847209
    [Abstract] [Full Text] [Related]

  • 10. Multiple states of opioid receptors may modulate adenylate cyclase in intact neuroblastoma X glioma hybrid cells.
    Costa T, Wüster M, Gramsch C, Herz A.
    Mol Pharmacol; 1985 Aug; 28(2):146-54. PubMed ID: 2991735
    [Abstract] [Full Text] [Related]

  • 11. Comparative pharmacological properties and functional coupling of mu and delta opioid receptor sites in human neuroblastoma SH-SY5Y cells.
    Kazmi SM, Mishra RK.
    Mol Pharmacol; 1987 Jul; 32(1):109-18. PubMed ID: 3037297
    [Abstract] [Full Text] [Related]

  • 12. Naltrexone-induced upregulation of mu opioid receptors on 7315c cell and brain membranes: enhancement of opioid efficacy in inhibiting adenylyl cyclase.
    Côté TE, Izenwasser S, Weems HB.
    J Pharmacol Exp Ther; 1993 Oct; 267(1):238-44. PubMed ID: 8229750
    [Abstract] [Full Text] [Related]

  • 13. Identification of three separate guanine nucleotide-binding proteins that interact with the delta-opioid receptor in NG108-15 neuroblastoma x glioma hybrid cells.
    Roerig SC, Loh HH, Law PY.
    Mol Pharmacol; 1992 May; 41(5):822-31. PubMed ID: 1317000
    [Abstract] [Full Text] [Related]

  • 14. Modification of G protein-coupled functions by low-pH pretreatment of membranes from NG108-15 cells: increase in opioid agonist efficacy by decreased inactivation of G proteins.
    Selley DE, Breivogel CS, Childers SR.
    Mol Pharmacol; 1993 Oct; 44(4):731-41. PubMed ID: 8232223
    [Abstract] [Full Text] [Related]

  • 15. Naloxonazine effects on the interaction of enkephalin analogs with mu-1, mu and delta opioid binding sites in rat brain membranes.
    Cruciani RA, Lutz RA, Munson PJ, Rodbard D.
    J Pharmacol Exp Ther; 1987 Jul; 242(1):15-20. PubMed ID: 3039108
    [Abstract] [Full Text] [Related]

  • 16. Nalbuphine: an autoradiographic opioid receptor binding profile in the central nervous system of an agonist/antagonist analgesic.
    De Souza EB, Schmidt WK, Kuhar MJ.
    J Pharmacol Exp Ther; 1988 Jan; 244(1):391-402. PubMed ID: 2826773
    [Abstract] [Full Text] [Related]

  • 17. BW373U86: a nonpeptidic delta-opioid agonist with novel receptor-G protein-mediated actions in rat brain membranes and neuroblastoma cells.
    Childers SR, Fleming LM, Selley DE, McNutt RW, Chang KJ.
    Mol Pharmacol; 1993 Oct; 44(4):827-34. PubMed ID: 8232233
    [Abstract] [Full Text] [Related]

  • 18. Properties of delta opioid receptor in neuroblastoma NS20Y: receptor activation and neuroblastoma proliferation.
    Law PY, Bergsbaken C.
    J Pharmacol Exp Ther; 1995 Jan; 272(1):322-32. PubMed ID: 7815347
    [Abstract] [Full Text] [Related]

  • 19. Opiate receptor down-regulation and desensitization in neuroblastoma X glioma NG108-15 hybrid cells are two separate cellular adaptation processes.
    Law PY, Hom DS, Loh HH.
    Mol Pharmacol; 1983 Nov; 24(3):413-24. PubMed ID: 6314114
    [Abstract] [Full Text] [Related]

  • 20. Delta opioid modulation of the binding of guanosine-5'-O-(3-[35S]thio)triphosphate to NG108-15 cell membranes: characterization of agonist and inverse agonist effects.
    Szekeres PG, Traynor JR.
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1276-84. PubMed ID: 9400003
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.